Abstract
INTRODUCTION
Ciliary beating is of particular importance in the activation of mucociliary clearance in the airway (Afzelius, 2004; Salathe, 2007; Wanner, Salathe, & O'Riordan, 1996) and is regulated by Ca 2+ and cAMP (Salathe, 2007; Smith, Shellard, Dhillon, Winter, & Mehta, 1996; Wanner et al., 1996) . The activities of ciliary beating are assessed by two parameters, ciliary bend angle (CBA) and ciliary beat frequency (CBF), in airway ciliary cells (Ikeuchi et al., , 2017 Kogiso et al., 2017a; Komatani-Tamiya et al., 2012) . Increases in CBA and CBF have been shown to enhance ciliary transport in experimental conditions (Komatani-Tamiya et al., 2012) .
The CBA and CBF are driven by two functionally distinct molecular motors, i.e. the inner dynein arm (IDA) and the outer dynein arm (ODA; Brokaw, 1994; Brokaw & Kamiya, 1987; Gibbons & Rowe, c 2017 The Authors. Experimental Physiology c 2017 The Physiological Society PDE1A, caused by a reduction in [Ca 2+ ] i , hastens the time course of the procaterol-induced increase in CBF by stimulating cAMP accumulation in the CBF-regulating metabolon (Kogiso et al., 2017a) . These results suggest that interactions between the Ca 2+ signal and cAMP signal play roles in the maintenance of adequate ciliary beating.
However, previous studies showed that reduction of [Ca 2+ ] i induced various CBF responses in airway ciliary cells; no change (Komatani-Tamiya et al., 2012; Li et al., 2012) , a decrease (Hayashi et al., 2005; Matsubara et al., 2007; Narumoto et al., 2013) or an increase (Kogiso et al., 2017a (Kogiso et al., , 2017b . The Ca 2+ and cAMP signals have been recognized independently to increase CBF in nasal ciliary cells (Smith et al., 1996) . However, we have found that the Ca 2+ -dependent PDE1, PDE1A, regulates cAMP accumulation in airway ciliary cells (Kogiso et al., 2017a) .
Thus, the effects of low [Ca 2+ ] i on CBF in airway ciliary cells are still controversial. Moreover, the effects of elevation of [Ca 2+ ] i on the cAMP-stimulated ciliary beating, especially CBF, still remain uncertain.
The aim of this study was to clarify the effects of [Ca 2+ ] i on CBA and CBF in airway ciliary cells of mice with or without cAMP accumulation.
METHODS

Ethical approval
The procedures and protocols for the experiments were approved by the Committee for Animal Research of Kyoto Prefectural University of . The animals were cared for and the experiments carried out according to the guidelines of this committee, which are identical to the principles and regulation described in the editorial by Grundy (2015) . Female mice (C57BL/6J, 5 weeks of age) were purchased from Shimizu experimental animals (Kyoto, Japan) and fed standard pelleted food and water ad libitum. The mice (5-10 weeks of age) were used for experiments. The mice were first anaesthetized by inhalation of isoflurane (3%), and then heparinized by I.P. injection of pentobarbital sodium (40 mg kg −1 ) plus heparin (1000 units kg −1 ).
After 15 min, the mice were killed with a high dose of pentobarbital sodium (100 mg kg −1 , I.P.).
Solutions and chemicals
The control solution had the following composition (mM): 121 NaCl, 4.5 KCl, 25 NaHCO 3 , 1 MgCl 2 , 1.5 CaCl 2 , 5 Na-Hepes, 5 Hepes and 5 glucose. To prepare the nominally Ca 2+ -free solution, CaCl 2 (1.5 mM) was omitted from the control solution, and to prepare the EGTA-containing Ca 2+ -free solution (EGTA solution), EGTA (1 mM) was added in the nominally Ca 2+ -free solution. The pH of each solution was adjusted to 7.4 by adding 1 M HCl or 1 M NaOH. All solutions were aerated with a gas mixture (95% O 2 -5% CO 2 ) at 37 • C.
Procaterol was a generous gift from Otsuka Pharmaceutical Co., Ltd (Tokyo, Japan), and 1 nM was used throughout the experiments.
Heparin, elastase and bovine serum albumin (BSA) were purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan). BAPTA-AM and fura-2 AM were from Dojindo Laboratories (Kumamoto, Japan 
Cell preparations
Post mortem, the lungs were cleared of blood by perfusion via the pulmonary artery using a nominally Ca 2+ -free solution containing heparin (20 units ml −1 ), and the lungs together with the trachea and heart were removed from the mouse en bloc. Lung epithelial cells, including airway ciliary cells, were isolated from the lungs. The procedure for cell isolation from the lungs has been described in detail elsewhere (Kogiso et al., 2017a; Komatani-Tamiya et al., 2012; Shiima-Kinoshita et al., 2004) . Briefly, the lung cavity was washed with a nominally Ca 2+ -free solution and then with the control solution.
After washing, the lung cavity was digested with control solution containing elastase (0.2 mg ml −1 ) and DNase I (0.02 mg ml −1 ) for 40 min at 37 • C. After this digestion, lungs were minced using fine forceps in the control solution containing DNase I (0.02 mg ml −1 ) and BSA (5%), and the minced tissue was filtered through a nylon mesh (a sieve having 300 m openings). The isolated cells were washed three times with centrifugation (160g for 5 min) and then resuspended in control solution at 4 • C. The cells were used for experiments within 5 h after isolation.
Measurement of CBA and CBF
The isolated cells were placed on a coverslip precoated with CellTak (Becton Dickinson Labware, Bedford, MA, USA), and the coverslip with cells was set in a microperfusion chamber (20 l) heated to 37 • C, because CBF is temperature dependent (Delmotte & Sanderson, 2006) . Ciliary beating was observed using an inverted light microscope (T-2000; Nikon, Tokyo, Japan) connected to a high-speed camera (IDP-Express R2000; Photron Ltd, Tokyo, Japan). The chamber was perfused with control solution aerated with a gas mixture (95% O 2 -5% CO 2 at 37 • C) at a constant rate (300 l min −1 ). Ciliary cells were distinguished from other lung epithelial cells by their beating cilia.
Ciliary cells accounted for around 10-20% of isolated lung cells. For the measurements of CBA and CBF, ciliary beating were recorded for 2 s at 500 frames s −1 . Before the start of experiments, the cells were perfused with control solution for 5 min, then with test solutions containing various drugs. After the experiments, CBA and CBF were measured using an image analysis program (DippMotion 2D; Ditect, Tokyo, Japan; Kogiso et al., 2017a; Komatani-Tamiya et al., 2012) .
A previous report has already described in detail the method for measurement of CBF and CBA (Komatani-Tamiya et al., 2012) . The 
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Measurement of [Ca 2+ ] i
[Ca 2+ ] i was measured using fura-2 fluorescence. Isolated ciliary cells were incubated with 2.5 M fura-2 acetoxymethyl ester (fura-2 AM) for 30 min at 37 • C. The fura-2 fluorescence was measured using an image analysis system (model ARGUS/HiSCA; Hamamatsu Photonics, Hamamatsu, Japan). The fura-2 was excited at 340 and 380 nm, and emission was measured at 510 nm. The fura-2 fluorescence ratio (F 340 /F 380 ) was calculated.
Statistical analysis
Data are expressed as means ± SD. Statistical significance was assessed by ANOVA or Student's paired or unpaired t test, as appropriate. Differences were considered significant at P < 0.05. Addition of 8MmIBMX gradually increased both CBF and CBA in the (Kogiso et al., 2017a) . These results suggest that 10 M BAPTA-AM has a sufficient Ca 2+ -chelating capacity to preventing an increase in [Ca 2+ ] i by mechanical stimulation (Li et al., 2012) , but that it is not sufficient to decrease [Ca 2+ ] i to the concentration inhibiting PDE1 activity, which increases CBF.
RESULTS
Effects of [Ca
To confirm the action of intracellular Ca 2+ on CBF and CBA, we examined the effects of calmidazolium (25 M; a calmodulin inhibitor) on CBF and CBA, because PDE1 is a Ca 2+ -calmodulin-dependent enzyme (Bender & Beavo, 2006) . Addition of 25 M calmidazolium induced increases in CBF and CBA by 10-15%, which were inhibited by pretreatment with PKI-A (Figure 2c ). However, a previous study by Salathe and Bookman (1999) found that CBF in cultured ovine tracheal ciliary cells was decreased by calmidazolium at 1 M, which is lower than the 25 M applied in the present study. The experiments were also carried out using 5 M calmidazolium, instead of 25 M.
Addition of 5 M calmidazolium decreased CBF, but did not change CBA (Figure 2d ). Thus, an extremely low [Ca 2+ ] i or an extremely high concentration of calmidazolium increased CBF via cAMP accumulation by inhibiting PDE1. The CBF responses observed in the previous studies (Li et al., 2012; Salathe & Bookman, 1999) were caused by relatively lower concentrations of BAPTA-AM or calmidazolium compared with those used in the present study.
We also examined the effects of removal of BAPTA-AM and calmidazolium on CBF and CBA. Removal of BAPTA-AM and calmidazolium at all concentrations used in the present study resulted in little recovery of CBA and CBF. We stress here that the BAPTA-AM at 50 M and calmidazolium at 25 M increased, 'not stopped' , CBA and CBF, which were PKI-A sensitive. However, the addition of 50 M calmidazolium completely stopped ciliary beating (data not shown). These observations suggest that the machinery of ciliary beating controlled by PKA and adenylyl cyclase activities (cAMP production), at least, are maintained, 'not collapsed' , even in the presence of BAPTA-AM at 50 M and calmidazolium at 25 M. We think that BAPTA-AM at 50 M and calmidazolium at 25 M do not affect cell viability, although we never neglect the possibility that their unknown toxic actions increase CBF and CBA. increased CBF and CBA (Figure 3c) . Interestingly, the time course of the procaterol-stimulated CBF increase in nominally Ca 2+ -free solution was much faster than that in the control solution containing ionomycin (Figure 3a and c) , whereas the time courses of CBA increase were similar irrespective of ionomycin treatment.
Effects of high [Ca
To analyse quantitatively the time courses of CBF and the CBA increase, as shown in Figure 3a and c, the procaterol-stimulated increases in CBF and CBA were fitted to an exponential curve,
where a is the value at t = ∞ in each experiment, t is the time after procaterol stimulation, and is the time constant in the change of CBF or CBA); was used to assess the rate of increase of CBF or CBA stimulated by procaterol. Figure 3d (a and c) , the procaterol-induced increases in CBF and CBA were fitted to an exponential curve, of the form a[1 − exp(−t/ )] (where a is the value at t = ∞ in each experiment, t is the time after procaterol stimulation, and is the time constant in the change of CBF or CBA). The value of was used to assess the rate of increase of CBF or CBA stimulated by procaterol. The rate of procaterolstimulated CBF increase was higher in nominally Ca 2+ -free solution than in the control solution containing ionomycin, although the time courses of procaterol-stimulated CBA increase were similar in both experiments data, CBF and CBA. The value of for the procaterol-stimulated CBF increase in the nominally Ca 2+ -free solution was 2.58 ± 0.51 min (n = 6), and that in the control solution containing ionomycin was 5.15 ± 2.19 min (n = 9). The in the ionomycin-containing control solution was significantly larger than that in the nominally Ca 2+ -free condition (P < 0.05). Unlike CBF, the value of for procaterol stimulation in CBA (0.80 ± 0.16 min, n = 4) in the nominally Ca 2+ -free solution was identical to that (0.85 ± 0.34 min, n = 7) in the control solution containing 1 M ionomycin. These results suggest that procaterol stimulates a slower cAMP accumulation in the CBFregulating metabolon in high- [Ca 2+ ] i conditions than in low-[Ca 2+ ] i conditions.
In the next experiments, we also studied the effect of ionomycin (1 M) on the increase in CBF and CBA sustained by 1 nM procaterol stimulation (Figure 4a) . Interestingly, ionomycin gradually decreased the CBF and CBA sustained by 1 nM procaterol by 10% (Figure 4a ).
Removal of procaterol and ionomycin rapidly decreased CBF and CBA. In the absence of 8MmIMX, removal of procaterol and ionomycin decreased CBF and CBA by 82 and 54%, respectively, whereas in the presence of 8MmIBMX, removal of procaterol and ionomycin decreased CBF and CBA by 29 and 12%, respectively. In the control experiments (procaterol stimulation without ionomycin), removal of procaterol decreased CBF and CBA by 51 and 24%, respectively (data not shown). Thus, ionomycin enhanced the decreases in CBF and CBA after the removal of procaterol. These observations appear to support the idea that ionomycin stimulates breakdown of cAMP to decrease the procaterol-stimulated CBF and CBA.
As shown in a previous report (Kogiso et al., 2017a) , airway ciliary cells contain PDE1A and PDE1C in the cell body and PDE1A in the cilia. However, an increase in [Ca 2+ ] i stimulated by 1 M ionomycin did not completely inhibit the increase in CBA and CBF stimulated by 1 nM procaterol (Figures 3a and 4a) . The previous report also demonstrated that the amount of cAMP accumulated as a result of PDE1 inhibition is much less than that accumulated by IBMX (Kogiso et al., 2017a ).
These observations suggest that the activities of PDE1A and PDE1C 
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DISCUSSION
The effects of low [Ca 2+ ] i on CBF in unstimulated airway ciliary cells were controversial. Kogiso et al. (2017a) reported that lowering the [Ca 2+ ] i increases CBF, whereas it has been reported that lowering the [Ca 2+ ] i decreases CBF (Hayashi et al., 2005; Matsubara et al., 2007; Narumoto et al., 2013) , and also that it does not change CBF (Komatani-Tamiya et al., 2012; Li et al., 2012) In studies on Chlamydomonas (Brokaw, 1994; Brokaw & Kamiya, 1987) , the inner dynein arms (IDAs) control CBA and the ODAs (outer dynein arms) control CBF. PDE1A exists in the metabolon regulating ODAs, not IDAs in the cilia of airway ciliary cells, although it also exists in the cell body (Kogiso et al., 2017a) . PDE1C is also expressed in the cell body, but not in the cilia of the airway ciliary cells. The complete inhibition of PDE1 caused by some compounds, such as 8MmIBMX, induces cAMP accumulation in the cell body and the cilia, elevating both CBA and CBF. The previous study suggests that the cilium is a special space isolated from the cell body and that the cAMP concentration appears to be higher in the cilium compared with the cell body during procaterol stimulation (Kogiso et al., 2017a) . Therefore, PDE1A plays a crucial role in control of We also used ionomycin at 1 M. In the presence of 1 M ionomycin, procaterol (1 nM) still increased CBA and CBF, even though it fully activated PDE1. However, ionomycin at this concentration completely abolished the increase in CBF and partly inhibited the In the present study, we measured cAMP using cells isolated from the lungs. In our cell preparation, the cells isolated from the lung cavity, not the trachea, contain alveolar epithelial cells (80%) and airway ciliary cells (20%), and the percentages of other cell types are negligibly small (Hosoi et al., 2002) . Changes in the cAMP contents were measured not only in the ciliary cells but also in the alveolar epithelial cells. However, the results obtained in CBA and CBF measurement using PKI-A are consistent with those obtained in the cAMP measurement. At least, it appears to be certain that lowering [Ca 2+ ] i accumulates cAMP via inhibition of PDE1 in airway ciliary cells.
In conclusion, cAMP accumulation in the airway cilia is regulated by 
